Bicycle Therapeutics (BCYC) Asset Utilization Ratio (2019 - 2026)
Bicycle Therapeutics (BCYC) reported Asset Utilization Ratio of 0.09 for Q1 2026, up 231.68% on a YoY basis from 0.03 in Q1 2025, and down 5.4% quarter-over-quarter from 0.1 in Q4 2025.
Bicycle Therapeutics (BCYC) Asset Utilization Ratio (2019 - 2026) Analysis & Trends
Bicycle Therapeutics has reported Asset Utilization Ratio for 8 years, with the latest figure at 0.09 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio rose 231.68% year-over-year to 0.09; the trailing twelve-month figure through Mar 2026 stood at 0.09 (up 231.68% YoY), and the FY2025 full-year result was 0.09, up 90.75% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.09, down from 0.1 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.1 in Q4 2025, with the low at 0.02 in Q2 2025.
- Historically, Asset Utilization Ratio has averaged 0.05 across 5 years, with a median of 0.04 in 2022.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio slumped 57.13% — and 2025, when it jumped 266.09%.
- Bicycle Therapeutics' Asset Utilization Ratio stood at 0.06 in 2022, then fell by 23.65% to 0.04 in 2023, then slumped by 38.78% to 0.03 in 2024, then jumped by 266.09% to 0.1 in 2025, then decreased by 5.4% to 0.09 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.09 (Q1 2026), 0.1 (Q4 2025), and 0.04 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Bicycle Therapeutics | 278.04 Mn | 278.04 Mn | - | 0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.09 |
| Dec 31, 2025 | 0.10 |
| Sep 30, 2025 | 0.04 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.03 |
| Dec 31, 2024 | 0.03 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.06 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.05 |
| Jun 30, 2023 | 0.06 |
| Mar 31, 2023 | 0.06 |
| Dec 31, 2022 | 0.06 |
| Sep 30, 2022 | 0.04 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | 0.05 |
| Jun 30, 2021 | 0.05 |